PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Quick Stats
Feb 02, 202651.8
AI Score
HOLD0.66
Volume Ratio
Mar 26, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
PDSB Stock Summary
Last updated Feb 02, 2026
PDSB is currently trading at $0.8262, positioned below its 200-day moving average of $1.13, suggesting bearish momentum. The stock has a 52-week range of $0.7201 to $2.2.
Technical Analysis: The 50-day moving average stands at $0.89, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.888, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.257, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PDSB at 51.8/100 with a HOLD recommendation.
PDSB (PDS Biotechnology Corporation Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.888 |
| CMF (20) | -0.257 |
| ROC (10) | -13.15 |
| ADX (14) | 15.261 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.012 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -94.811 |
| MFI (14) | 33.867 |
PDSB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PDSB Price vs Max Options Open Interest
PDSB Max Change In Options Open Interest
PDSB Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PDSB Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PDSB Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PDSB Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PDS Biotechnology Corporation Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PDSB Moving Averages Analysis
PDSB (PDS Biotechnology Corporation Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 0.91 |
| 20 | 0.93 |
| 30 | 0.91 |
| 50 | 0.89 |
| 100 | 0.94 |
| 200 | 1.13 |
PDSB Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 45.6 million |
| Earnings/Share ($) | -0.81 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.8 |
| EPS Estimate Next Year ($) | -0.68 |
| WallStreet Target Price ($) | 7.5 |
| Most Recent Quarter |